DMAC Operating Income Growth
Diamedica Therapeutics Inc · Operating Income Growth
DMAC Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-26.54%period ending
DMAC Quarterly Operating Income YoY % (-53.61% → -26.54%)
Year-over-year change
High-resolution chart · PNG
DMAC operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -26.5393% | |
| -28.7083% | |
| -9.431% | |
| -31.2364% | |
| -42.0184% | |
| -41.8568% | |
| -43.9637% | |
| -33.4691% | |
| -18.9201% | |
| -3.9848% | |
| -47.1936% | |
| -64.8657% | |
| -40.9334% | |
| -56.1369% | |
| -22.3968% | |
| 8.4309% | |
| 0.0297% | |
| 2.2935% | |
| 23.9456% | |
| -2.9226% | |
| -24.2614% | |
| -50.5408% | |
| -54.0794% | |
| -24.7275% | |
| 1.2039% | |
| 29.7281% | |
| -64.1998% | |
| -87.4867% | |
| -40.5181% | |
| -598.0336% | |
| -45.0163% | |
| -297.0411% | |
| -277.5174% | |
| -137.9165% | |
| -291.2838% | |
| -25.2043% | |
| 99.012% | |
| 247.7842% | |
| 35.609% | |
| 439.959% | |
| 70.264% | |
| -8.3058% | |
| -41.3985% | |
| 120.236% | |
| -74.0392% | |
| -79.8627% | |
| -35.4886% | |
| -167.204% | |
| -42.9432% | |
| -25.8462% | |
| -60.5527% | |
| -49.4043% | |
| -13.7867% | |
| 47.4581% | |
| 250.9295% | |
| 46.9175% | |
| 66.4026% | |
| 12.8403% | |
| -16.7901% | |
| 281.2549% | |
| 343.2415% | |
| 265.016% | |
| -236.1615% | |
| -58.4779% | |
| -28.7763% | |
| -31.4294% | |
| -228.5632% | |
| -190.0926% | |
| -177.4981% | |
| 49.8121% | |
| -37.1384% | |
| 69.6687% | |
| -37.9494% | |
| 355.1362% | |
| 214.5977% | |
| 105.1469% | |
| 33,768.1699% | |
| -6,064.1546% | |
| 477.8938% | |
| 472.4077% | |
| 105.9929% | |
| -53.6144% |